Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage

Clinical trial NCT02359162 · TERMINATED

Trial details

NCT number: NCT02359162
Sponsor: Sun Yat-sen University
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphoma, Extranodal NK-T-Cell

Start date: 2015-05-01
Primary completion: 2017-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.